However, there are conflicting results whether exposure to anti-IgM in vitro promotes or suppresses apoptosis in CLL cells[6] and other signals provided by the tumor microenvironment likely determines the outcome[7]. The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.